Group One Trading
PPBT

Group One Trading’s Purple Biotech PPBT Stock Holding History

Group One Trading’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-250
Closed -$1.64K – 8497
2025
Q4 		$1.64K Buy
+250
New +$1.81K ﹤0.01% 7611
2025
Q1 		– Sell
-3,440
Closed -$161K – 8213
2024
Q4 		$161K Buy
+3,440
New +$132K ﹤0.01% 4104
2022
Q4 		– Sell
-25
Closed -$10K – 7904
2022
Q3 		$10K Sell
25
-11
-31% -$5.14K ﹤0.01% 6507
2022
Q2 		$17K Sell
36
-2
-5% -$1.2K ﹤0.01% 6415
2022
Q1 		$30K Buy
38
+19
+100% +$12.3K ﹤0.01% 6476
2021
Q4 		$14K Buy
19
+6
+46% +$5.11K ﹤0.01% 7185
2021
Q3 		$12K Hold
13
– – ﹤0.01% 7428
2021
Q2 		$12K Buy
+13
New +$11.9K ﹤0.01% 7457

Other funds holding PPBT

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Group One Trading's PPBT Position: Q1 2026 in Review

Group One Trading reduced its Purple Biotech (PPBT) stake by 31% in Q1 2026, selling an estimated $49 and leaving 20 shares worth $81. The position accounts for ﹤0.01% of the portfolio, ranked #7434.

Group One Trading first reported a position in PPBT in Q1 2021 and has held it in 18 quarters since. The position peaked at $214K in Q3 2021. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • Group One Trading held 20 shares of Purple Biotech worth $81 as of Q1 2026.
  • Group One Trading sold 9 Purple Biotech shares in Q1 2026, an estimated $49.
  • Purple Biotech made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7434 holding.
  • Group One Trading first reported a position in Purple Biotech in Q1 2021 and has held it in 18 quarters since.
  • Group One Trading's Purple Biotech position peaked at $214K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.